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Abstract
In developing countries, low levels of awareness, cost and organizational constraints on access to
specialized care contribute to inadequate patient help-seeking behavior. As much as 95% of cancer
patients in developing countries are diagnosed at late to end stage disease. Consequently,
treatment outcome is dismally poor and a vicious cycle sets in, with public mystification of cancer
and the admonishment of cancer medicine as a futile effort, all, to the further detriment of patient
help-seeking behavior and treatment engagement. The situation spirals down, when the practice of
cancer medicine is not gratifying to the medical practitioner and does not appeal as a medical
specialty to those in training. The future of cancer medicine in developing countries thus hinges on
the demystification of cancer through positive information, coupled to an effective organization that
allows for the optimal use of available resources, facilitates access to specialized care and promotes
the flow of knowledge and technology amongst various stakeholders. This paper strives to make a
cogent argument and highlight the capital importance of information and communication
technologies in organizing and leveraging scarce resources for cancer education, research and
practice in developing countries.
Background
Developing countries currently bear fifty-percent of the
global cancer burden and, are projected to bear sixty-per-
cent by the year 2020 [1]. The rise in the cancer case-inci-
dence is for the most part ascribed to social, lifestyle and
environmental changes concurrent with economic devel-
opment and globalization [2,3]. Primarily, the resources
mobilized towards improving public health practices and
health care delivery, have significantly improved the con-
trol capacity of acute life-threatening conditions,
increased life expectancies and brought forth chronic con-
ditions such as cancer. Contemporaneously, the HIV/
AIDS burden of developing countries would go from a
"plague-like" to a manageable chronic endemic condition
with its associated malignant complications [4,5]. Sec-
ondarily, economic development is bringing about life-
style changes that significantly increase the lifetime risk of
developing cancer. Notable lifestyle changes include a sig-
nificant uptake in tobacco and alcohol; increased con-
sumption of processed foods low in fiber and high in
refined sugars and saturated fat; increased sedentariness as
a result of the mechanization of household chores, trans-
portation and industrial activities [2,3]. Furthermore,
increased industrial activity results in an increase in envi-
ronmental pollutants and lifetime exposure to carcino-
gens [2].
Published: 03 January 2006
Health Research Policy and Systems 2006, 4:1 doi:10.1186/1478-4505-4-1
Received: 07 September 2005
Accepted: 03 January 2006
This article is available from: http://www.health-policy-systems.com/content/4/1/1
© 2006 Andela; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Health Research Policy and Systems 2006, 4:1 http://www.health-policy-systems.com/content/4/1/1
Page 2 of 5
(page number not for citation purposes)
In the wake of an overwhelming cancer case-incidence, an
already over-extended healthcare system gives way. Pres-
ently, because of low levels of awareness and the cost and
organizational constraints on access to specialized care as
much as 95% of cancer patients in developing countries
are diagnosed at late or end stage disease [6-8]. Conse-
quently, treatment outcome is dismally poor [9-11]. A
vicious cycle sets in, with public mystification of cancer
and the admonishment of cancer medicine as a futile
effort, all to the further detriment of patient help-seeking
behavior and treatment engagement. The situation spirals
down, when the practice of cancer medicine is not gratify-
ing to the medical practitioner and does not appeal as a
medical specialty to those in training.
By contrast, with existing knowledge and technology, the
concerted action of governments, non-governmental
organizations and healthcare systems in developed coun-
tries can prevent a third of cancers, provide treatment to
another third and palliative care to those in need [12].
While this represents a significant stride in the "war
against cancer", cancer remains the leading cause of mor-
bidity and mortality in developed countries [1,13,14].
This mandates for sustained efforts in the areas of popula-
tion / epidemiological, and clinical research, where cer-
tain limitations have emerged that must be emphasized.
Primarily, the relative homogeneity of lifestyle and envi-
ronmental exposure in developed countries limits the
study of cancer promoting and counteracting factors [2].
Secondly, with almost daily and exponential advances in
basic and translational research findings, novel cancer
drugs and cancer preventive and therapeutic strategies are
designed yet not tested because of a contracting patient
pool available and willing to participate in clinical trials
[15,16]. It is in fact estimated that more than 80% of bio-
technology and pharmaceutical companies miss their
deadlines for patient enrollment and loose over 1.3 mil-
lion dollars in direct and opportunity cost [17]. Overarch-
ingly, the culture of science in western societies has not
wholly integrated the complementary culture of science in
other societies [18]. As a matter of fact, cross-collabora-
tions yield profound results and there is much to be
gained from engaging a south-south and north-south
dynamic [2,18,19].
Hardware and network architecture Figure 1
Hardware and network architecture: Global satellite communications using very small aperture terminals (VSAT) are 
widely distributed in urban and sub-urban localities, where economic transitions concur with a rise in cancer case incidences 
[3]. Widespread connectivity (Internet user) and the added potential for interactivity with the mobile user, all at low to 
minimal cost, supports the use of these media in cancer education and advocacy efforts.Health Research Policy and Systems 2006, 4:1 http://www.health-policy-systems.com/content/4/1/1
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Bridging the chasm
Historically, the sharing advantage of nascent technolo-
gies has spurred leaps and bounds in human develop-
ment. This is evident in the telescoping timelines of
human development milestones, from a ten thousandth
year lapse for the onset of the agricultural revolution, to a
four hundredth year lapse for the scientific revolution and
then a one hundredth year lapse for the industrial revolu-
tion. In order, the information revolution heralds an
unsurpassed leap in national, international and global
development, by granting access to knowledge, cognitive
tools and organizational support and permitting a greater
fraction of the global community to actualize their human
potentials and participate in a global intelligent network.
By virtue of its sharing advantage (portability and afford-
ability), developing countries have in recent times, known
an excess of 263% growth in telecommunications and
Internet connectivity [20,21]. The growth and penetration
of telecommunications and Internet connectivity in devel-
oping countries has in fact already triggered a wide scale
and successful adoption of such media in various devel-
opment initiatives operating at the grass-roots level, nota-
bly in the areas of education and healthcare [22-24]. Such
initiatives set precedence and chart a path for the success-
ful implementation of the information and communica-
tion technologies (ICTs) towards enhancing cancer
education, research and practice.
Cancer education
Knowledge, positive information and advocacy are cor-
nerstones of cancer survivorship [25,26]. In developing
countries, the low level of cancer knowledge and aware-
ness in the general population has had devastating conse-
quences. Generally, cancer is mystified, preventative
actions are not taken and treatment engagement is defi-
cient. Mass education, positive information and advocacy
should thus be a mainspring in capacity building. By rais-
ing the level of awareness, a critical mass would be
attained and a dynamic intercourse would result amongst
patients, providers, policy makers and the public, towards
mobilizing resources and taking corrective action. The
penetration of ICTs in developing countries validates their
utility as a mass media with unique advantages over tradi-
tional (audio-visual) mass media. Notably, the Internet
medium grant(s) access to interactive tools that generate
evidence-based medical information pertinent to cancer
prevention and treatment and customized to the individ-
uals' unique characteristics [27,28]. Furthermore, the
interactivity afforded by online chat-rooms, e-mails and
more importantly wireless application protocols (short
messages services sent to individual cell phone users), all
at minimal to no cost, gives tremendous potential for a
sustainable effort in individualized and customized edu-
cation, advocacy and support.
Cancer research
Information engenders research and research engenders
information. To this end, the Internet would not only
serve the informational and educational purposes, but
would inherently result in the digitization of data, proce-
dures and processes and set up the quintessence of a rig-
orous and viable research enterprise: speed, control,
accountability, cost-containment and patient-provider
engagement and satisfaction [29,30].
Cancer practice
Optimal cancer patient care is multidisciplinary and at its
bare minimum, calls for the timely and concerted opinion
and action of the patient; the primary care physician; the
pathologist; the medical oncologist; the radiation oncolo-
gist and the surgical oncologist [31]. In the setting of a
developing country, multidisciplinary cancer patient care
is limited by educational, cost and organizational con-
straints [6-11]. The uninformed patient seeks medical
attention from inadequate sources and expends a great
deal of resources in the process [8]. These deficiencies are
compounded by the limited number of trained profes-
sionals in cancer medicine and the quasi inexistence of
professional networks[3,8,9]. Again the Internet medium
Public-patient-physician networks Figure 2
Public-patient-physician networks: With the digitization 
and storage of data, procedures and processes, a rigorous 
research enterprise and evidence-based medical practice 
would result, characterized by speed, control, accountability, 
cost-containment and patient-provider engagement and satis-
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would not only serve the informational and educational
purposes, but would inherently result in a self-organized
community wherein cancer patients and care providers
seamlessly interact. Harnessing the organizational sup-
port the Internet medium affords, would clearly result in
speed, control, accountability, cost-containment and
patient-provider engagement and satisfaction [29,30].
Recommendation and conclusion
The strength of ICTs should be harnessed to engage a
south-south and north-south dynamic. While laudable
efforts are being made towards building the cancer control
capacity of developing countries, by transfering technol-
ogy from developed countries [32,33], the prevailing plat-
form, that is humanitarian aid and distributive justice, is
weak and potentially detrimental [34,35]. Transferring
appropriate knowledge and technology from developed
countries is desirable, yet should not undermine the
opportunities that abound in developing countries and
that should be transformed and harnessed towards
improved cancer care [2,17]. It is intended that putting a
spotlight on these opportunities and threats would stimu-
late improved and dynamic partnerships in the global
fight against cancer [36].
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